~
23/8/2019, asx , verbatim,
US Listing Update
~23 August 2019
G MEDICAL US LISTING UPDATE
.Withdrawal of NASDAQ capital raising prospectus to allow for formal filing of OTC listing
Dual listing on OTCQB will be non-dilutive to existing G Medical shareholders
OTC affords the same access to institutional and individual investors
Increasing US operational and investor footprint remain a key focus
HKSE Listing of ‘Yimei’ continues
.Mobile and e-Health company G Medical Innovations Holdings Limited (ASX: GMV) (“G Medical” or the “Company”) wishes to update its shareholders on it US Public Offering strategies.
.The Company has made a decision to withdraw the Company's NASDAQ registration statement on form F1 filing (“F1 Prospectus”) (refer to the ASX announcement dated 20 May 2019) and will instead pursue an OTC (over the counter) listing on the OTCQB (“OTC”), a US based financial market. With the decision of the F1 Prospectus withdrawal now effectuated, the Company anticipates the filing in respect to the OTC listing with the US Securities and Exchange Commission (SEC) to occur in the coming weeks …..”
~
Dyor.
At least read this asx ann in full.
~
ps
As mentioned, yacov is likely to revisit Nasdaq/CR after he gets Nmpa/Boletong/Silverlake & HKSE/GYimei, later this year
- Forums
- ASX - By Stock
- GMV
- GMV The Future
GMV The Future, page-1209
-
- There are more pages in this discussion • 1,805 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LGP
Record revenue of $10.2 million as European demand drives 40% quarterly growth, with $1 million in operating cash inflow and $0.5 million in cost savings forecast
SBW
Shekel Brainweigh reports a 50% revenue increase in its Retail Innovation suite and delivers the first batch of 20 Smart Bays to Hitachi as part of a larger order